Advance Solid Malignancies
1 clinical trials · Condition
◉ Watch Advance Solid Malignancies
| Record | Firm | Date |
|---|---|---|
| A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Advanced/Metastatic Solid Malignancies (NCT04850755) | National University Hospital, Singapore | 2021-03-08 |
Track Advance Solid Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.